Table 5.
Prevalence of ATP-III MetS at visit 1 (overall; unadjusted)
| n | % (95% CI)a | p-valueb | |
|---|---|---|---|
| Everyday discrimination | .2690 | ||
| Low (n = 1,275, 1.15 ± 0.17) | 291 | 22.8 (20.6, 25.2) | |
| Median (n = 1,336, 1.91 ± 0.24) | 287 | 21.5 (19.3, 23.8) | |
| High (n = 1,182, 3.32 ± 0.82) | 238 | 20.1 (17.9, 22.5) | |
| Lifetime discrimination | .4431 | ||
| Low (n = 1,640, 1.04 ± 0.83) | 371 | 22.6 (20.6, 24.7) | |
| Median (n = 1,167, 3.46 ± 0.50) | 241 | 20.7 (18.4, 23.1) | |
| High (n = 921, 5.93 ± 1.02) | 197 | 21.4 (18.8, 24.2) | |
| Discrimination burden | .0736 | ||
| Low (n = 1,115, 1.50 ± 0.34) | 241 | 21.6 (19.2, 24.2) | |
| Median (n = 1,005, 2.34 ± 0.19) | 199 | 19.8 (17.4, 22.4) | |
| High (n = 1,048, 3.20 ± 0.39) | 251 | 24.0 (21.4, 26.7) |
Low first tertile; median second tertile; high third tertile; CI confidence interval.
aClopper–Pearson (exact) confidence limits.
bChi-square test.